Bellerophon Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2014 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2014 to Q3 2023.
  • Bellerophon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.92M, a 62.1% increase year-over-year.
  • Bellerophon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$9.25M, a 51.5% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.8M, a 11.7% decline from 2021.
  • Bellerophon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.8M, a 28.2% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$24.7M, a 86.4% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$9.25M -$1.92M +$3.15M +62.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$12.4M -$5.14M -$1.03M -25.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$11.4M $2.82M +$8.46M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$19.8M -$5.02M -$744K -17.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$19.1M -$5.07M -$435K -9.39% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$18.7M -$4.11M -$716K -21.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$17.9M -$5.64M -$180K -3.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$17.8M -$4.27M +$3.73M +46.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$21.5M -$4.63M +$3.3M +41.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$24.8M -$3.39M +$431K +11.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$25.2M -$5.46M -$491K -9.88% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$24.7M -$8.01M -$3.93M -96.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$20.8M -$7.93M -$3.65M -85% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17.2M -$3.82M +$285K +6.94% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$17.4M -$4.97M -$4.18M -525% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$13.3M -$4.08M -$3.17M -347% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$10.1M -$4.29M -$15.4M -139% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $5.29M -$4.11M +$7.37M +64.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$2.08M -$795K -$4.89M -119% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $2.81M -$912K +$23.2M +96.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 -$20.4M $11.1M +$18.7M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$39.1M -$11.5M -$7.54M -192% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$31.6M $4.1M +$23.2M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$54.8M -$24.2M -$16.7M -225% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-15
Q3 2017 -$38.1M -$7.59M -$3.39M -80.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$34.7M -$3.93M +$1.21M +23.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$35.9M -$19.1M -$12.1M -171% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$23.8M -$7.42M +$3.4M +31.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$27.2M -$4.2M +$6.95M +62.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$34.2M -$5.14M +$6.45M +55.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$40.6M -$7.06M +$5.85M +45.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$46.5M -$10.8M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$11.1M +$4.34M +28% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$11.6M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$12.9M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 -$15.5M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.